← Back to Clinical Trials
Recruiting NCT07028554

NCT07028554 Post-Market Clinical Follow-Up Study Plan for Cartridges of Disposable Endoscopic Linear Cutting Staplers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07028554
Status Recruiting
Phase
Sponsor Suzhou Care-Real Medical Technology Co., Ltd.
Condition the Transection of Tissues
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2025-01-10
Primary Completion 2025-07-15

Trial Parameters

Condition the Transection of Tissues
Sponsor Suzhou Care-Real Medical Technology Co., Ltd.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-01-10
Completion 2025-07-15
Interventions
Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered Endoscopic Linear Cutting Staplers and Disposable Endoscopic Linear Cutting Staplers manufactured by Ningbo Verykind Medical Device Co., Ltd. have marketed in many countries or area for many years. The investigational devices are intended for transection, resection, and/or creation of anastomoses. The instruments have application in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures. In order to confirm the safety and performance of the products, as well as the continued safety and clinical performance of the implant (the staple) during the clinical follow-up period, monitor the identified side-effects, contraindications and identify previously unknown side-effects, and ensure the continued acceptability of the benefit-risk ratio, Investigators proactively collect and evaluate clinical data from different regions, including of Italy, Brazil and Chile, where the device has been marketed, and conduct PMCF studies.

Eligibility Criteria

Inclusion Criteria: 1. Age≥18 years old, gender unlimited; 2. The surgery type shall be open or endoscopic surgery; 3. The departments of surgical procedures: general, gynecologic, urologic and thoracic surgical procedures; 4. Investigational devices listed in this PMCF plan must be used during surgical procedures. Exclusion Criteria: 1. Patients with surgical contraindications to the product, e.g. use the instruments on large arteries, on ischemic or necrotic tissue, use the device on tissues with a compression thickness out of the device range; 2. Concomitant with similar devices (staplers/reloads/cartridges, etc.) for resection, transection and anastomosis of surgical organ or tissues; 3. The operation record is incomplete, and the information related to the main indicators cannot be extracted.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology